SNHG12 is highly expressed in gastric carcinoma, non‐small cell lung cancer, and liver carcinoma, and is involved in tumor development and drug resistance, which is an underlying therapeutic target and biomarker for human cancers.29 Here, SNHG12 is linked to hepatocellular carcinoma.